CVS Q3 earnings on deck: What to expect

What happened

CVS is due to report third-quarter results on November 4 before markets open. Analysts expect earnings per share to rise 3.1% and revenue to climb nearly 2% to $104.69B, with attention on margins in the Aetna, Health Care Benefits and Caremark businesses.

Confirmed

Global impact / market context

CVS blends insurance, pharmacy services and drugstores, so profit per sale depends on how each piece performs. Watch Aetna's margins, which means the share of revenue kept as profit, because weaker pricing or higher medical costs can offset revenue growth and pressure results.

Analyst inference

Analyst estimates are mixed: profit forecasts had more cuts than raises, while revenue forecasts had mostly raises, suggesting doubts about profitability despite expected sales growth. Management has flagged headwinds in the 340B drug discount business and expected Caremark membership losses in 2027.

Analyst inference

What to watch

1. Aetna margins and results from the Health Care Benefits and Caremark businesses, the areas analysts are watching when CVS reports quarterly results on November 4. Confirmed
2. Whether CVS updates its outlook for 2027, including the flagged 340B drug discount headwind and expected Caremark membership decline from health plan customers exiting. Proposed
3. Whether the new pricing model at Caremark pressures membership or revenue, and whether past beats on revenue estimates repeat this quarter. Analyst inference

Affected assets

• OP — Optimism

Evidence

• seekingalpha.com